Xcout Intel
Nosis Bio
Nosis Biosciences develops receptor-targeted RNA medicines utilizing its proprietary AI-powered platform, Connexa, which combines physics-aware deep learning, single cell biology, and high-throughput chemistry. The company's platform designs gene-silencing therapeutics intended to treat chronic conditions across various cell types and organ systems, including the heart, lungs, kidneys, and brain.
Subscribe to see Nosis Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nosis Bio at a glance
Nosis Bio is a biotech company. Xcout tracks 3 named people at Nosis Bio, including Jim Martineau (CEO & Cofounder). Xcout recorded 2 job postings from Nosis Bio in the last 90 days.
Nosis Bio leadership
- Jim MartineauCEO & Cofounder
- Seth MyersCTO & Cofounder
- Chad MillerHead of Research Platform & Cofounder
Hiring at Nosis Bio
Xcout recorded 2 job postings from Nosis Bio in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Nosis Bio's hiring signals →
Nosis Bio competitors
A few of Nosis Bio's closest competitors — see the full list of competitors and alternatives →
Manifold Biotechnologies, Inc. develops biotechnology solutions for biologic drug discovery and development, specializing in molecular tracking and high-throughput in vivo screening. The company builds an AI-guided direct-to-vivo discovery platform designed to accelerate the development of tissue-targeted medicines, including RNA interference treatments for neurological diseases.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Skip Therapeutics is an Israeli biotechnology company founded in 2021 and based in Ness Ziona. The company develops personalized RNA-based therapies, including antisense oligonucleotides, for rare genetic disorders and common diseases using a proprietary computational discovery engine.
Convexia is a biotechnology research company headquartered in San Francisco, California, United States. It utilizes an end-to-end AI stack to quickly find and acquire early-stage drugs, replacing traditional manual diligence processes with fast execution.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Get Nosis Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Nosis Bio? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nosis Bio in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access